TORONTO, ON — Takeda Canada Inc. (“Takeda”) announces results from the EVOLVE Expansion study, which evaluated the safety and efficacy of vedolizumab (ENTYVIO®), a gut-selective α4β7-integrin inhibitor and ustekinumab (UST), an… Read More
Poster highlights pravibismane’s MIC activity in testing against aerobic and anaerobic pathogens isolated from diabetic foot infection patients Pravibismane demonstrated potent, broad-spectrum activity against a wide range of pathogens, including… Read More
Scientists at Simon Fraser University (SFU) and the Lankenau Institute for Medical Research (LIMR) near Philadelphia have found that a drug discovered at SFU and patented several years ago may… Read More
VANCOUVER, BC — LifeLabs is thrilled to share that Jennifer Cudlipp, Chief Operating Officer, has been named one of Vancouver’s Top 25 Executive for 2023 by C-Suite Spotlight. This prestigious… Read More
First study to assess histologic changes in the kidneys of patients with lupus nephritis treated with LUPKYNIS® (voclosporin) Treatment was not associated with chronic injury, with the average chronicity index remaining… Read More
